Overview
Top Medical Research Studies
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
Throughout 2012 to 2014, conventional treatments fell short in resolving her symptoms, despite her undergoing canalith repositioning treatments (CRTs). Remarkably, in 2015, we noted a correlation between her self-treatment of vitamin D—at a dose of 5000 IU daily—and the subsequent resolution of her vertigo symptoms.
This case stands out not just because of the uncommon progression from single-canal to multi-canal BPPV, but also highlights the potential role of vitamin D in symptom management. It suggests that vitamin D might offer benefits for those suffering from dizziness related to vertigo, particularly in cases where traditional treatments are ineffective.
Our findings revealed that the average serum vitamin D level in patients who had recurring BPPV was significantly lower (12.9 ng/mL) compared to those without recurrences (19.2 ng/mL). This suggests that lower vitamin D levels might be linked to a higher chance of dizziness from BPPV recurrences.
We also identified that a vitamin D level below 12.74 ng/mL was associated with a significantly higher recurrence rate of 70.5%, compared to just 22.5% for those above this threshold. This indicates that monitoring and managing vitamin D levels could be crucial for patients at risk for recurring episodes of BPPV.
In summary, our findings underline the potential importance of vitamin D in managing dizziness, particularly in individuals suffering from BPPV. It seems that keeping an adequate level of this vitamin might help reduce the risk of future vertigo episodes.
Most Useful Reviews
Medical Researches
- All Researches
Throughout 2012 to 2014, conventional treatments fell short in resolving her symptoms, despite her undergoing canalith repositioning treatments (CRTs). Remarkably, in 2015, we noted a correlation between her self-treatment of vitamin D—at a dose of 5000 IU daily—and the subsequent resolution of her vertigo symptoms.
This case stands out not just because of the uncommon progression from single-canal to multi-canal BPPV, but also highlights the potential role of vitamin D in symptom management. It suggests that vitamin D might offer benefits for those suffering from dizziness related to vertigo, particularly in cases where traditional treatments are ineffective.
To understand her condition better, we conducted an electrophysiological assessment of her vestibular function, which revealed a typical response associated with benign paroxysmal positional vertigo (BPPV). Notably, we found that the patient had a deficiency in vitamin D levels in her serum.
After a 7-day treatment using Epley's maneuver, which is a common approach for BPPV, the patient's symptoms resolved completely. This highlights the importance of recognizing BPPV as a potential complication after stapes surgery, especially when vitamin D levels are low.
Our findings suggest that monitoring serum levels of total calcium and vitamin D could be crucial not only for understanding dizziness but also in preventing its recurrence after such surgeries.
The first group received vitamin D3 along with a combination of alpha-lipoic acid, Carnosine, and Zinc, as well as vitamins from the B group. The second group, with sufficient vitamin D but no supplementation, served as a control. Meanwhile, the third group had sufficient vitamin D and received a different antioxidant mix.
After a six-month follow-up, we observed a significant reduction in dizziness relapses only among those in the first group who had insufficient or deficient vitamin D levels prior to treatment. Unfortunately, the other groups did not show similar improvements. This highlights the importance of addressing vitamin D deficiency, especially for those prone to recurrent dizziness. However, we must be cautious, as the combination of different supplements makes it challenging to isolate the effects solely attributed to vitamin D3.
Over the course of two months, the treatment group raised their vitamin D levels significantly, while the control group did not see any change. Following this treatment period, we observed a remarkable difference in the recurrence of BPPV attacks; the group receiving vitamin D3 experienced far fewer episodes compared to the control group.
Our results indicate that boosting vitamin D3 levels significantly reduces the number of recurrent dizziness episodes in patients with BPPV. This suggests that addressing vitamin D deficiency may play a key role in managing dizziness in affected patients.
In our study, we enrolled 100 patients diagnosed with BPPV and measured their Vitamin D levels. Based on these measurements, we classified participants as having deficient, insufficient, or sufficient Vitamin D levels. Those with deficiencies received Vitamin D supplementation of 2000 IU daily for six months.
Over the course of a year, we followed these patients monthly, monitoring both the frequency and severity of their BPPV episodes using the Vertigo Symptom Scale. Our findings were quite significant: those with Vitamin D deficiency experienced BPPV at a rate of 71%, compared to only 20% in those who had sufficient Vitamin D levels. Moreover, the severity of vertigo symptoms was notably higher in the deficient group.
Importantly, we observed that supplementation appeared to reduce both the incidence and severity of BPPV episodes over time. This highlights the potential role of Vitamin D in supporting vestibular health and suggests it may be a valuable component of managing BPPV. However, further controlled studies are needed to fully understand these connections and their implications for patient care.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Dizziness is a term that describes a range of sensations, including feelings of lightheadedness, unsteadiness, or a false sense of spinning, often referred to as vertigo. This condition can be caused by various factors, including inner ear problems, dehydration, low blood pressure, or certain medications. While it might feel like a minor annoyance for some, dizziness can be a warning sign of more serious health issues, particularly if it is sudden or accompanied by other symptoms such as headache, vision changes, or difficulty speaking.
For those experiencing occasional dizziness, remedies may include staying hydrated, avoiding sudden movements, and engaging in balance exercises. However, persistent dizziness warrants a consultation with a healthcare provider, as it can signify underlying health concerns like vestibular disorders or neurological conditions. Understanding the root cause of dizziness is crucial for effective management, whether through lifestyle modifications or more involved medical treatments.
Vitamin D is a fat-soluble vitamin that's essential for maintaining healthy bones and teeth, supporting immune system function, and facilitating normal cell growth and development. It plays a crucial role in calcium absorption in the gut, which is vital for bone health. Unlike most vitamins, our bodies can produce Vitamin D when exposed to sunlight, specifically UVB rays, which is why it’s often referred to as the "sunshine vitamin." However, depending on your geographical location, lifestyle, and skin type, getting sufficient Vitamin D from the sun alone can be challenging, particularly during the winter months.
In addition to sunlight, Vitamin D can be obtained from certain foods such as fatty fish (like salmon and mackerel), fish liver oils, and fortified foods like milk and cereals. Some individuals may also consider supplements, especially if they're at risk for deficiency. Insufficient vitamin D levels are linked to various health issues, including rickets in children, osteomalacia in adults, and even an increased risk of chronic diseases. Regularly checking your vitamin D levels and consulting with a healthcare professional can help ensure you're meeting your needs for optimal health.
According to user reviews, individuals taking this supplement for dizziness often report varying timelines for noticeable results. Many users suggest improvements can be seen within a few weeks to a month of consistent use. For instance, one reviewer highlighted that after taking the supplement for about a month, their vitamin D deficiency symptoms, including dizziness, showed significant improvement (Read Review). Another user mentioned feeling relief from dizziness and fatigue shortly after starting a weekly regimen (Read Review), while others pointed out a noticeable difference in symptoms upon waking (Read Review).
Overall, users tend to agree that regular use is key, and while some experience quicker relief, a period of a few weeks is generally a common timeframe for seeing positive effects on dizziness attributed to vitamin D supplementation.
Numerous studies indicate that vitamin D supplementation may significantly benefit individuals suffering from dizziness related to Benign Paroxysmal Positional Vertigo (BPPV). For instance, one clinical trial revealed that older adults receiving vitamin D showed an impressive 87% reduction in BPPV recurrence rates, suggesting that addressing vitamin D deficiency could play a crucial role in managing dizziness associated with this condition [17]. Additionally, another research study indicated that patients with BPPV who had adequate vitamin D levels experienced a substantial decrease in both the frequency and severity of their vertigo episodes compared to those with deficiencies [2].
Furthermore, a systematic review found that vitamin D supplementation not only reduced vertigo recurrence but also improved patients' quality of life by alleviating dizziness symptoms tied to BPPV [16]. The connection between vitamin D deficiency and dizziness is further underscored by research showing that individuals with lower vitamin D levels exhibited higher rates of BPPV, reinforcing the idea that appropriate vitamin D management could enhance treatment outcomes and reduce dizziness episodes [6]. Overall, while vitamin D is not a standalone treatment, it emerges as a supportive option worth considering for individuals struggling with dizziness related to BPPV.
Based on user reviews, many individuals report significant improvements in symptoms related to dizziness and fatigue after incorporating vitamin D supplementation into their routines. For instance, one user noted feeling relief from dizziness and fatigue shortly after starting a weekly regimen (Read Review). Another reviewer experienced a marked increase in energy levels and a complete disappearance of dizziness upon waking after consistent use (Read Review).
Additionally, several users highlighted that their overall health, including symptoms like lethargy and bone pain, improved dramatically after taking the supplement. One user reported that all their symptoms vanished after incorporating it into their daily routine (Read Review). While results can vary between individuals, the consensus among users is that regular consumption of vitamin D leads to noticeable, and often rapid, relief from symptoms associated with deficiency.
According to user reviews, many individuals have reported positive experiences when combining this vitamin D supplement with others for alleviating dizziness. For example, one user mentioned finding relief from dizziness and fatigue after taking the vitamin D pill along with cod liver oil (Read Review). Another reviewer experienced improved health, stating that using this product in conjunction with Centrum +50 and Vitamin K2 led to a significant reduction in low pressure and dizziness (Read Review).
Additionally, users tend to emphasize the importance of absorption by suggesting that vitamin D should be taken with meals for maximum effectiveness and improved symptom relief (Read Review). Overall, the feedback indicates that combining this supplement with others can enhance its efficacy and contribute to more consistent improvements in symptoms associated with dizziness.
Research suggests that vitamin D supplementation can significantly reduce the symptoms of dizziness, particularly in individuals with Benign Paroxysmal Positional Vertigo (BPPV). One study identified that participants who were vitamin D deficient and received daily doses of 2000 IU over six months experienced a marked decrease in both the frequency and severity of their BPPV episodes compared to those with sufficient vitamin D levels who did not require supplementation [2]. Furthermore, another trial found a remarkable 87% reduction in recurrence rates for those treated with vitamin D3, indicating its potential effectiveness in managing dizziness associated with BPPV [17].
For individuals grappling with dizziness due to BPPV, a dosage of around 2000 IU daily has shown promising results in clinical trials. However, it's crucial to note that those with severe deficiencies might benefit even more from higher doses. For instance, a case was observed where a patient taking 5000 IU daily saw complete resolution of dizziness symptoms [7]. Overall, while optimal dosages may vary depending on individual vitamin D levels and specific health conditions, a regimen of 2000 IU to 5000 IU appears to be a prudent starting point for those looking to mitigate dizziness linked to BPPV.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
In our study, we enrolled 100 patients diagnosed with BPPV and measured their Vitamin D levels. Based on these measurements, we classified participants as having deficient, insufficient, or sufficient Vitamin D levels. Those with deficiencies received Vitamin D supplementation of 2000 IU daily for six months.
Over the course of a year, we followed these patients monthly, monitoring both the frequency and severity of their BPPV episodes using the Vertigo Symptom Scale. Our findings were quite significant: those with Vitamin D deficiency experienced BPPV at a rate of 71%, compared to only 20% in those who had sufficient Vitamin D levels. Moreover, the severity of vertigo symptoms was notably higher in the deficient group.
Importantly, we observed that supplementation appeared to reduce both the incidence and severity of BPPV episodes over time. This highlights the potential role of Vitamin D in supporting vestibular health and suggests it may be a valuable component of managing BPPV. However, further controlled studies are needed to fully understand these connections and their implications for patient care.
What we found is quite interesting. One randomized clinical trial suggested that supplementing vitamin D significantly reduced the recurrence of vertigo in patients with low levels of this vitamin. More specifically, the study indicated that vitamin D supplementation brought down the annual recurrence rate, showcasing the potential benefits of optimizing vitamin D levels for those suffering from BPPV.
However, it’s important to note that while the one rigorous study pointed out positive effects, non-randomized studies suggested there could be little to no impact. Given this mixed evidence, we conclude that while vitamin D might play a role in managing BPPV, we still need more high-quality research to firmly establish these findings.
Our findings revealed that about 52% of these patients experienced recurring episodes of BPPV. We noticed that higher serum vitamin D levels were associated with a reduced likelihood of experiencing these recurrences. Specifically, for each increment in vitamin D levels, patients were 16.7% less likely to face repeated bouts of dizziness. Interestingly, a history of migraines did not show a significant connection to BPPV recurrence in our study.
While we established a clear association between vitamin D levels and the frequency of dizziness episodes, we also noted that there wasn't a significant difference in the duration of these episodes based on vitamin D status. Looking ahead, we recommend conducting further research, particularly randomized controlled trials, to test the effects of vitamin D supplementation on BPPV and determine the best dosages for those affected.
Throughout 2012 to 2014, conventional treatments fell short in resolving her symptoms, despite her undergoing canalith repositioning treatments (CRTs). Remarkably, in 2015, we noted a correlation between her self-treatment of vitamin D—at a dose of 5000 IU daily—and the subsequent resolution of her vertigo symptoms.
This case stands out not just because of the uncommon progression from single-canal to multi-canal BPPV, but also highlights the potential role of vitamin D in symptom management. It suggests that vitamin D might offer benefits for those suffering from dizziness related to vertigo, particularly in cases where traditional treatments are ineffective.
References
- Huang X, Chua KW, Moh SPS, Yuen HW, Low DYM, et al. Falls and physical function in older patients with Benign Paroxysmal Positional Vertigo (BPPV): findings from a placebo controlled, double blinded randomized control trial (RCT) investigating efficacy of vitamin D treatment in lowering the recurrence rate of BPPV. Aging Clin Exp Res. 2025;37:43. doi:10.1007/s40520-025-02938-4
- Kumar S, Dutta A, Biradar K, Gupta M. Evaluating the Vitamin D Deficiency-BPPV Link: Correlation or Causation?. Indian J Otolaryngol Head Neck Surg. 2024;76:5263. doi:10.1007/s12070-024-04961-9
- Aygun D, Dumur S, Elgormus MN, Alpaslan MS, Uzun H. Serum Otoconin-90 and Otolin-1 Concentrations in Benign Paroxysmal Positional Vertigo. Biomolecules. 2024;14. doi:10.3390/biom14101279
- Lin T, Wu C, Zhang L, Ding L. Association of vitamin-D deficiency with vestibular function in patients with idiopathic benign paroxysmal positional vertigo. J Laryngol Otol. 2025;139:40. doi:10.1017/S0022215124001282
- Chua KW, Huang X, Koh XH, Soh JFJY, Barrera VC, et al. Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults. Otolaryngol Head Neck Surg. 2025;172:127. doi:10.1002/ohn.954
- Chu C, Chan YM, Tang J. Clinical Outcomes in Patients With Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency: A Singaporean Perspective. Cureus. 2024;16:e60325. doi:10.7759/cureus.60325
- Abedi MS, Flink TS, Roca CP. A Rare Presentation of Multicanal Benign Paroxysmal Positional Vertigo in a Premenopausal Woman With Osteopenia: A Case Report. Cureus. 2024;16:e55421. doi:10.7759/cureus.55421
- Rhim G, Kim MJ. Vitamin D Supplementation and Recurrence of Benign Paroxysmal Positional Vertigo. Nutrients. 2024;16. doi:10.3390/nu16050689
- Saeed Al-Rawi TS, Al-Ani RM. Vitamin D Deficiency and the Risk of Recurrent Benign Paroxysmal Positional Vertigo. Cureus. 2024;16:e52433. doi:10.7759/cureus.52433
- Chauhan I, Sidhu J, Lal B, Dhadwal M, Azad R. Role of Serum Markers in Benign Paroxysmal Positional Vertigo: Are They Useful?. Indian J Otolaryngol Head Neck Surg. 2023;75:1731. doi:10.1007/s12070-023-03727-z
- Zubčić Ž, Včeva A, Mendeš T, Maleš J, Mihalj H, et al. SUCCESSFUL REPOSITIONING PROCEDURE FOR BENIGN PAROXYSMAL POSITIONAL VERTIGO AFTER STAPEDOTOMY. Acta Clin Croat. 2022;61:547. doi:10.20471/acc.2022.61.03.22
- Sharma K, Ojha T, Dabaria R, Chhabra B, Trivedi BB, et al. Relation Between Posterior Canal Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency. Indian J Otolaryngol Head Neck Surg. 2022;74:4405. doi:10.1007/s12070-021-03070-1
- Shin HI, Park Y, Lee HJ, Jeon EJ. Correlation between serum vitamin D level and benign paroxysmal positional vertigo recurrence. Auris Nasus Larynx. 2023;50:700. doi:10.1016/j.anl.2022.12.017
- Mancera Sánchez J, Hernaiz Leonardo JC, Ishiwara Niembro JK, Lesser JC. Therapeutic Effect of the Correction of Vitamin D Deficiency in Patients with Benign Paroxysmal Positional Vertigo. A Randomized Clinical Trial. Int Arch Otorhinolaryngol. 2022;26:e666. doi:10.1055/s-0041-1730992
- Libonati GA, Leone A, Martellucci S, Gallo A, Albera R, et al. Prevention of Recurrent Benign Paroxysmal Positional Vertigo: The Role of Combined Supplementation with Vitamin D and Antioxidants. Audiol Res. 2022;12:445. doi:10.3390/audiolres12040045
- Hong X, Christ-Franco M, Moher D, Tse D, Lelli DA, et al. Vitamin D Supplementation for Benign Paroxysmal Positional Vertigo: A Systematic Review. Otol Neurotol. 2022;43:e704. doi:10.1097/MAO.0000000000003586
- Chua KW, Huang X, Koh XH, Soh JFJY, Barrera VC, et al. Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults. Otolaryngol Head Neck Surg. 2025;172:127. doi:10.1002/ohn.954
- Libonati GA, Leone A, Martellucci S, Gallo A, Albera R, et al. Prevention of Recurrent Benign Paroxysmal Positional Vertigo: The Role of Combined Supplementation with Vitamin D and Antioxidants. Audiol Res. 2022;12:445. doi:10.3390/audiolres12040045
- Gu X, Dong F, Gu J. Analysis of effect of 1α-hydroxyvitamin D3 on benign paroxysmal positional vertigo and risk factors. Exp Ther Med. 2018;15:2321. doi:10.3892/etm.2018.5699
- Sheikhzadeh M, Lotfi Y, Mousavi A, Heidari B, Bakhshi E. The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study. Caspian J Intern Med. 2016;7:173.
- Sheikhzadeh M, Lotfi Y, Mousavi A, Heidari B, Monadi M, et al. Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study. Caspian J Intern Med. 2016;7:93.
- Talaat HS, Kabel AM, Khaliel LH, Abuhadied G, El-Naga HA, et al. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2016;43:237. doi:10.1016/j.anl.2015.08.009
- Mori K, Niimura S, Mizuno K. [A case of idiopathic hypoparathyroidism complicated with chronic thyroiditis]. Nihon Naibunpi Gakkai Zasshi. 1991;67:1339.
